首页> European urology> Final results of an EORTC-GU cancers group randomized study of maintenance bacillus calmette-gu??rin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: One-third dose versus full dose and 1 year versus 3 years of maintenance

Final results of an EORTC-GU cancers group randomized study of maintenance bacillus calmette-gu??rin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: One-third dose versus full dose and 1 year versus 3 years of maintenance

导出原文传递

翻译打印收藏纠错

第一作者： Oddens,J.

作者： Oddens,J. ^[1] ; Brausi,M. ^[2] ; Sylvester,R. ^[3] ; Bono,A. ^[4] ; VanDeBeek,C. ^[5] ; VanAndel,G. ^[6] ; Gontero,P. ^[7] ; Hoeltl,W. ^[8] ; Turkeri,L. ^[9] ; Marreaud,S. ^[10] ; Collette,S. ; Oosterlinck,W.

作者单位： Department of Urology, Ospedale di Circolo, Varese, Italy ^[1] Department of Urology, OLVG, Amsterdam, Netherlands ^[2] Department of Urology, Ospedale Molinette, Torino, Italy ^[3] Department of Urology, B. Ramazzini Hospital, Modena, Italy ^[4] Department of Urology, Marmara University, School of Medicine, Istanbul, Turkey ^[5] Department of Urology, Jeroen Bosch Ziekenhuis, PO Box 90153, 5200 ME's-Hertogenbosch, Netherlands ^[6] Department of Urology, Academisch Ziekenhuis Maastricht, Maastricht, Netherlands ^[7] Department of Urology, UZ Gent, Ghent, Belgium ^[8] Headquarters, European Organization for Research and Treatment of Cancer (EORTC), Brussels, Belgium ^[9] Department of Urology, Kaiser-Franz-Josef Spital, Vienna, Austria ^[10]

关键词 Adjuvant treatment Bacillus Calmette-Guerin Immunotherapy Maintenance therapy Non-muscle invasive bladder cancer Randomized Controlled Trial Urinary bladder

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交